The global blood glucose monitor market is forecast to grow from about USD 16.5 billion in 2025 to USD 25.4 billion by 2030, representing a compound annual growth rate (CAGR) of approximately 9.1 % over the period, according to a new industry report. The expansion reflects a combination of rising diabetes prevalence, a growing geriatric population, and increased awareness and adoption of self-monitoring technologies globally.
Technological advancements are a key driver of this growth. Innovations such as continuous glucose monitoring (CGM) systems, integration with smartphones and wearable devices, and AI-based data analytics have improved device accuracy, convenience and patient engagement, accelerating adoption across home and clinical settings. Supportive government initiatives, enhanced healthcare infrastructure, and the availability of home-use monitoring options also contribute to adoption momentum in both developed and developing regions.
Among product types, self-monitoring blood glucose systems currently command the largest market share due to their ease of use and cost-effectiveness for everyday glucose tracking. Applications tied to diabetes management are expected to grow rapidly as the global burden of type 1 and type 2 diabetes continues to increase, pushing demand for reliable and real-time glucose monitoring solutions.
North America is forecast to remain the largest regional market, supported by advanced healthcare systems, favorable reimbursement policies, and high rates of technology adoption. The presence of major industry players and ongoing product innovation reinforce the region’s leading position, while emerging markets are poised for accelerated growth as access to diagnostic technologies improves.
The report’s findings indicate sustained demand for blood glucose monitoring devices as part of broader efforts to improve diabetes care, enhance patient outcomes, and enable proactive health management.
